Drugs / KAN-004
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07196410 | Mar 2026 → Dec 2028 expected | chemotherapy-induced toxicity, colitis | University of Montreal Hospital Centre (CHUM) | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KAN-004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07196410 ↗ |
| Route | Oral | “intended for oral administration” NCT07196410 ↗ |